Aminologics Financial Statements From 2010 to 2024

074430 Stock  KRW 1,011  7.00  0.69%   
Aminologics CoLtd financial statements provide useful quarterly and yearly information to potential Aminologics CoLtd investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Aminologics CoLtd financial statements helps investors assess Aminologics CoLtd's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Aminologics CoLtd's valuation are summarized below:
Aminologics CoLtd does not presently have any fundamental signals for analysis.
Check Aminologics CoLtd financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aminologics CoLtd's main balance sheet or income statement drivers, such as , as well as many indicators such as . Aminologics financial statements analysis is a perfect complement when working with Aminologics CoLtd Valuation or Volatility modules.
  
This module can also supplement various Aminologics CoLtd Technical models . Check out the analysis of Aminologics CoLtd Correlation against competitors.

Aminologics CoLtd Company Current Valuation Analysis

Aminologics CoLtd's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Aminologics CoLtd Current Valuation

    
  238.08 B  
Most of Aminologics CoLtd's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aminologics CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Aminologics CoLtd has a Current Valuation of 238.08 B. This is much higher than that of the Chemicals sector and significantly higher than that of the Materials industry. The current valuation for all Republic of Korea stocks is significantly lower than that of the firm.

Aminologics CoLtd Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aminologics CoLtd's current stock value. Our valuation model uses many indicators to compare Aminologics CoLtd value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aminologics CoLtd competition to find correlations between indicators driving Aminologics CoLtd's intrinsic value. More Info.
Aminologics CoLtd is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The ratio of Return On Equity to Return On Asset for Aminologics CoLtd is about  280.42 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aminologics CoLtd by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aminologics CoLtd's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Aminologics CoLtd Financial Statements

Aminologics CoLtd stakeholders use historical fundamental indicators, such as Aminologics CoLtd's revenue or net income, to determine how well the company is positioned to perform in the future. Although Aminologics CoLtd investors may analyze each financial statement separately, they are all interrelated. For example, changes in Aminologics CoLtd's assets and liabilities are reflected in the revenues and expenses on Aminologics CoLtd's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Aminologics CoLtd. Please read more on our technical analysis and fundamental analysis pages.
,Ltd., a specialty amino acid provider, develops a range of amino-acid-based raw materials for pharmaceutical and fine chemical industries in South Korea. ,Ltd. was founded in 1997 and is headquartered in Seoul, South Korea. AMINOLOGICS is traded on Korean Securities Dealers Automated Quotations in South Korea.

Pair Trading with Aminologics CoLtd

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aminologics CoLtd position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aminologics CoLtd will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aminologics Stock

  0.67051910 LG ChemicalsPairCorr
  0.66005490 POSCO HoldingsPairCorr
  0.62009830 Hanwha SolutionsPairCorr
  0.63011170 Lotte Chemical CorpPairCorr
  0.79004020 Hyundai SteelPairCorr

Moving against Aminologics Stock

  0.67001430 SeAH BesteePairCorr
The ability to find closely correlated positions to Aminologics CoLtd could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aminologics CoLtd when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aminologics CoLtd - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aminologics CoLtd to buy it.
The correlation of Aminologics CoLtd is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aminologics CoLtd moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aminologics CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aminologics CoLtd can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Aminologics Stock

Aminologics CoLtd financial ratios help investors to determine whether Aminologics Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aminologics with respect to the benefits of owning Aminologics CoLtd security.